NeurogesX - Ownership and Business Overview

Life ScienceCompany

NeurogesX Ownership

Who owns NeurogesX?

NeurogesX is owned by Acorda Therapeutics. It was acquired on July 9, 2013.

Was NeurogesX formerly PE-backed?

Yes. NeurogesX was formerly owned by 1 private investor.

NeurogesX Business Overview

Where is NeurogesX headquartered?

NeurogesX is headquartered in San Mateo, California.

What sector is NeurogesX in?

NeurogesX is a life science company.

When was NeurogesX founded?

NeurogesX was founded in 1998.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

NeurogesX, Inc.

999 Baker Way, Suite 200,
San Mateo, California 94404
United States,
(650) 358-3300
www.neurogesx.com

NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life. NeurogesX was founded in 1998 and is based in San Mateo, California.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.